Stock in Ariad Pharmaceuticals Inc., Celgene Corp., YM Biosciences Inc. and other hemtaology-focused biotech companies trended upward Friday in anticipation of results presented over the weekend at the 53rd Annual American Society of Hematology meeting in San Diego.